Raumedic Announces FDA Clearance of NEUROVENT®-PTO; a Multimodal Catheter for Monitoring of Brain Tissue pti02, ICP and ICT.
Raumedic, developer and manufacture of innovative neuromonitoring devices is pleased to announce the 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market NEUROVENT-PTO. NEUROVENT-PTO is the only marketed device that combines three parameters in one catheter to measure intracra…








